Products

AmCAD-UV
AmCad BioMed
Cardiology AI
AmCAD-UV is an AI-powered ultrasound software device for vascular pulsatility analysis, quantifying and classifying ultrasonic color intensity data to assist in interpreting hemodynamic variations in blood vessels.
AmCAD-UO
AmCad BioMed Corporation
Radiology & Imaging AI
AmCAD-UT
AmCad BioMed Corporation
Endocrinology & Metabolic AI

See all 3 products →

About AmCad BioMed

AmCad BioMed is a Taiwan-based healthcare AI company specializing in AI-powered ultrasound solutions for early and accurate disease diagnosis. Founded in 2008 and listed on the Taipei Exchange (Ticker: 4188), the company develops patented ultrasound AI technologies to assist physicians in detecting diseases faster and interpreting images with greater consistency.

These solutions aim to provide high value-added medical solutions for a wide variety of clinical applications, bolstering clinicians’ expertise with AI-driven technology and offering detailed quantification and visualization of sonographic characteristics.

Focus Areas

AI-powered ultrasound computer-assisted detection and diagnosis (CAD) thyroid cancer analysis obstructive sleep apnea detection breast lesion detection fatty liver analysis liver fibrosis analysis medical imaging software development

Business Intelligence

TechnologyAI-powered ultrasound software solutions, patented algorithms for quantification and visualization of sonographic characteristics, laser-guided robotic arm for consistent ultrasound imaging

What Physicians Need to Know

AI-Powered Ultrasound Solutions
AmCad BioMed specializes in integrating artificial intelligence into ultrasound imaging to enhance diagnostic accuracy and streamline workflows. Their solutions aim to revolutionize how healthcare professionals diagnose and treat patients.
Thyroid Cancer Analysis (AmCAD-UT)
AmCAD-UT is the world's first ultrasound CAD system for thyroid cancer detection and analysis. It assists physicians in assessing thyroid nodules with high accuracy and efficiency by processing ultrasound images for sonographic characteristics using statistical pattern recognition and quantification methods.
Obstructive Sleep Apnea (OSA) Detection (AmCAD-UO)
AmCAD-UO redefines OSA assessment and treatment using ultrasound AI. It offers an AI-enabled solution for OSA assessment, including AI-powered collapse risk detection in upper airway regions and trackable treatment monitoring with a patented laser-guided robotic arm for consistent image capture.
Breast Lesion Detection (AmCAD-UB)
AmCAD-UB enhances breast ultrasound scans with BI-RADS insights, aiming to improve the detection of breast cancers, especially in women with dense breast tissue where standard imaging alone might miss up to 50% of cancers.
Fatty Liver and Liver Fibrosis Analysis (AmCAD-US)
AmCAD-US unlocks soft tissue insights in various organs, providing enhanced tissue clarity through ultrasound backscatter analysis. It offers dual-mode imaging (B-mode and color-mapped US mode) and supports liver fibrosis assessment and pediatric hepatic steatosis assessment for early-stage diagnosis.
Medical Imaging Software Development
AmCad BioMed develops patented ultrasound AI technologies and innovative Computer-Assisted Detection (CAD) devices that provide detailed quantification and visualization of sonographic characteristics. Their software solutions are designed to streamline workflows and enhance diagnostic accuracy.
Physician Tip

AmCad BioMed's solutions offer physicians tools to accelerate ultrasound exams with real-time intelligence, enhance diagnostic accuracy by reducing subjective interpretation discrepancies, and redefine assessment and treatment pathways for conditions like OSA. The AI-driven technology provides detailed quantification and visualization of sonographic characteristics, bolstering clinical expertise and enabling more confident decision-making. Their systems are designed to assist in early and accurate diagnosis, particularly in challenging areas like indeterminate thyroid nodules and missed breast cancers in dense tissue.

AmCad BioMed's focus is on developing and commercializing their own core-technology platforms and patented algorithms for AI-powered ultrasound solutions. While specific third-party integrations are not detailed, their emphasis on streamlining workflows and enhancing diagnostic accuracy suggests their systems are designed to integrate into existing clinical practices.

Products by AmCad BioMed

3 products in the directory

AmCAD-UV
AmCad BioMed
Cardiology AI
AmCAD-UV is an AI-powered ultrasound software device for vascular pulsatility analysis, quantifying and classifying ultrasonic color intensity data to assist in interpreting hemodynamic variations in blood vessels.
AmCAD-UO
AmCad BioMed Corporation
Radiology & Imaging AI
AmCAD-UT
AmCad BioMed Corporation
Endocrinology & Metabolic AI

Videos

News, demos, and interviews about AmCad BioMed.

Loading videos...

Videos load interactively. If none appear, search YouTube for AmCad BioMed →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

AmCad BioMed specializes in AI-powered ultrasound solutions for early and accurate diagnosis. Their products include AmCAD-UT for thyroid cancer analysis, AmCAD-UO for obstructive sleep apnea detection, AmCAD-UB for breast lesion detection, and AmCAD-US for general soft tissue analysis, including fatty liver and liver fibrosis.
AmCad BioMed's CAD systems, such as AmCAD-UT for thyroid nodules and AmCAD-UO for obstructive sleep apnea, utilize patented AI algorithms to quantify and visualize sonographic characteristics. This technology helps physicians detect diseases faster, interpret images with greater consistency, and make more confident diagnostic decisions by providing detailed quantitative and visual data.
AmCad BioMed's products hold multiple FDA 510(k) clearances and CE Mark certifications. For example, AmCAD-UT, AmCAD-UO, AmCAD-US, and AmCAD-UV have all received FDA and CE Mark approvals, demonstrating their adherence to international medical device regulations.
AmCad BioMed, founded in 2008 and listed on the Taipei Exchange (Ticker: 4188), emphasizes responsible growth with strong investments in R&D. They actively seek international distributors and engage in cross-disciplinary collaboration in healthcare. While specific partnership details vary, their focus on pioneering ultrasound AI and expanding into point-of-care settings globally indicates a commitment to long-term stability and market reach.
Yes, AmCad BioMed's state-of-the-art pipeline aims for early detection and diagnosis of various diseases, including fatty liver and liver fibrosis. Their AmCAD-US product is designed to unlock soft tissue insights in various organs, which can be applied to the analysis of these liver conditions.
While specific details on support and training programs are not extensively detailed, AmCad BioMed's mission is to bolster clinicians' expertise with AI-driven technology and assist medical professionals in making more accurate early diagnoses. They provide contact information for inquiries, suggesting direct support for their products.

Related Companies

Radin Health offers a comprehensive suite of AI-powered, cloud-based solutions designed to enhance operational efficiency across all stages of the radiology workflow. Their platform integrates a Radiology Information System (RIS), Picture Archiving and Communication System (PACS), AI-driven Dictation, and RADIN SELECT for workflow management. These solutions aim to improve efficiency and productivity for administrators, medical […]

CompuGroup Medical is a leading software and e-health provider for doctors, hospitals, community health centers, laboratories, and more. The company offers a comprehensive suite of solutions that support the entire patient journey, from online scheduling and digital intake to AI-powered electronic health record (EHR) documentation, e-prescribing, lab connectivity, telehealth, remote patient monitoring, and revenue cycle […]

Spectrum Dynamics Medical is a pioneering medical device company focused on transforming nuclear medicine from analog to digital technology. They specialize in developing high-definition, solid-state based nuclear imaging technology, including digital SPECT (Single Photon Emission Computed Tomography) and SPECT/CT systems. Their products aim to meet the clinical needs and workflow demands of diagnostic imaging departments […]

Siemens Medical Solutions USA, Inc., operating as Siemens Healthineers USA, is a prominent medical technology company with a rich history spanning over 175 years, dedicated to pioneering breakthroughs in healthcare. As a subsidiary of the global Siemens Healthineers AG, the company offers a comprehensive portfolio that is central to clinical decision-making across the entire healthcare […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.